High Tower Advisors, LLC Adamis Pharmaceuticals Corp Transaction History

High Tower Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.14 - $0.22 $6,160 - $9,680	44,000 Added 329.59%	57,350 $9,000
Q3 2022 Nov 09, 2022	SELL	$0.24 - $0.54 $9,120 - $20,520	-38,000 Reduced 74.0%	13,350 $2,000
Q2 2022 Aug 10, 2022	BUY	$0.34 - $0.57 $680 - $1,140	2,000 Added 4.05%	51,350 $25,000
Q1 2022 May 12, 2022	BUY	$0.55 - $0.73 $5,500 - $7,300	10,000 Added 25.41%	49,350 $27,000
Q4 2021 Feb 10, 2022	SELL	$0.57 - $1.23 $16,929 - $36,531	-29,700 Reduced 43.01%	39,350 $23,000
Q3 2021 Nov 12, 2021	BUY	$0.92 - $1.18 $52,302 - $67,083	56,850 Added 465.98%	69,050 $66,000
Q2 2021 Aug 06, 2021	BUY	$0.66 - $1.23 $8,052 - $15,006	12,200 New	12,200 $13,000
Q2 2019 Aug 13, 2019	SELL	$1.26 - $2.23 $15,360 - $27,185	-12,191 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$2.25 - $4.8 $663 - $1,416	295 Added 2.48%	12,191 $44,000
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $5,610 - $10,670	2,200 Added 22.69%	11,896 $43,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $33,936 - $54,782	9,696	9,696 $43,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.